Ron Strine

DCO/CAPA Coordinator, Dentsply Sirona Preventive
  • Dentsply Sirona Preventive
  • United States of America

Recent Comments

Sep 06, 2017

September 6, 2017
 
Dear Author,

This request is in response to your publication, titled “Urinary triclosan concentrations and diminished ovarian reserve among women undergoing treatment in a fertility clinic. Fertility and Sterility, 2017, 108 (2), 312-319.        
 
Upon review of this publication, it was noted that “the results of this study were suggestive of a cumulative effect of chronic triclosan exposure that is potentially contributing to reduced fecundability and a need to seek treatment for infertility at a younger age.”
 
On behalf of manufacturer of a product with triclosan as an ingredient, as per the Pharmacovigilance regulations, we are required to investigate, collect, and submit adverse event reports.
 
Please note that patient confidentiality will be maintained at all times. Please take a few moments to review the requested information below:

Individual patient identifiers including demographics

Date of birth (as mentioned in the article)

Patients current conditions/concomitant medications

 
Any additional information you could provide would be greatly appreciated.


 Sincerely, 
  
Ron Strine
QA Specialist/DCO
Dentsply Sirona Preventive
Ronald.strineii@dentsplysirona.com
 
cc:  PR 1620327